2011
DOI: 10.18632/aging.100408
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass

Abstract: Recent studies suggest that oxytocin (Oxt) is implicated in energy metabolism. We aimed to explore acute and sub-chronic effects of peripheral Oxt treatment via different routes on food intake and energy balance. Intraperitoneal (ip) injection of Oxt concentration-dependently decreased food intake in mice. Ip Oxt injection induced c-Fos expression in the hypothalamus and brain stem including arcuate nucleus (ARC), paraventricular nucleus (PVN) and nucleus tractus solitarius (NTS). Subcutaneous (sc) injection o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

26
294
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 191 publications
(321 citation statements)
references
References 25 publications
(31 reference statements)
26
294
1
Order By: Relevance
“…Importantly, oxytocin has also been convincingly linked with protection from obesity [17][18][19][20][21][22][23]. While the nonapeptide oxytocin is historically recognized for its role in parturition [24] and lactation [25] it has gained more recent attention for its apparent effects on prosocial behavior [26,27] and therapeutic potential in the treatment of autism spectrum disorder (ASD) [26,27], schizophrenia [26,28] and obesity [17][18][19][20][21][22][23]. A large number of ongoing investigations in humans list oxytocin as the focus in studies on caloric intake, gastric emptying, or obesity, as displayed in the ClinicalTrials.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Importantly, oxytocin has also been convincingly linked with protection from obesity [17][18][19][20][21][22][23]. While the nonapeptide oxytocin is historically recognized for its role in parturition [24] and lactation [25] it has gained more recent attention for its apparent effects on prosocial behavior [26,27] and therapeutic potential in the treatment of autism spectrum disorder (ASD) [26,27], schizophrenia [26,28] and obesity [17][18][19][20][21][22][23]. A large number of ongoing investigations in humans list oxytocin as the focus in studies on caloric intake, gastric emptying, or obesity, as displayed in the ClinicalTrials.…”
Section: Introductionmentioning
confidence: 99%
“…gov registry, National Institutes of Health. Specifically, studies show oxytocin has roles in reducing food intake and body weight in dietinduced obesity [17,19,[21][22][23] in genetically obese rodent models [18,20,21], highlighting potential downstream CNS and peripheral mechanisms. It was also shown that intranasal administration of oxytocin in humans lowers caloric intake and has beneficial metabolic effects, resulting in a shift from carbohydrate to fat utilization and improved insulin sensitivity [29].…”
Section: Introductionmentioning
confidence: 99%
“…Various strategies have been proposed to treat obesity by promoting fat mobilization, increasing energy expenditure, and/or reducing food intake [1,7]. Accumulating evidence has shown that diets with higher protein and reduced carbohydrates are beneficial for weight loss and increase loss of body fat [8][9][10].…”
Section: Amino Acids and Obesitymentioning
confidence: 99%
“…Animals developed obesity when they were deficient of OT or OT receptors [15] [16]. Peripheral OT treatment reduced adipose tissue proportion and also ameliorated food intake, fatty liver, as well as glucose intolerance in ob/ob mice [17] [18] [19]. Adipocyte size was smaller after treating with OT, the lipogenic related genes fatty acid binding protein 4 (FABP4), peroxisomal proliferator activated receptor gamma (PPARÎł), glucose transporter 4 (GLUT4), and leptin mRNA levels in adipose tissues were increased in rats, indicating that OT treatment improves nutrient provision in adipose tissue [20].…”
mentioning
confidence: 99%
“…Glucagon and insulin were released by OT stimulations in isolated pancreas and islets of rodents [23] [24]. Daily peripheral injection and infusion of OT improved glucose tolerance test in mice with high-fat diet feeding [17] [25]. OT increased glucose uptake of cardiomyocytes through AKT/PKB phosphorylation in rodent [8] [26].…”
mentioning
confidence: 99%